In vivo studies have determined that an increase in the adiponectin level triggers a transient decrease in glucose by inhibiting expression of gluconeogenic enzymes in both wild-type and type 2 diabetic mice [67]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.